JP2025516407A5 - - Google Patents
Info
- Publication number
- JP2025516407A5 JP2025516407A5 JP2023560923A JP2023560923A JP2025516407A5 JP 2025516407 A5 JP2025516407 A5 JP 2025516407A5 JP 2023560923 A JP2023560923 A JP 2023560923A JP 2023560923 A JP2023560923 A JP 2023560923A JP 2025516407 A5 JP2025516407 A5 JP 2025516407A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- sodium
- ophthalmic composition
- group
- ophthalmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310476403.2A CN118892446A (zh) | 2023-04-27 | 2023-04-27 | 一种含vvn001的眼科组合物 |
| CN202310476403.2 | 2023-04-27 | ||
| PCT/CN2023/096273 WO2024221527A1 (zh) | 2023-04-27 | 2023-05-25 | 一种含vvn001的眼科组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516407A JP2025516407A (ja) | 2025-05-30 |
| JP2025516407A5 true JP2025516407A5 (https=) | 2025-10-03 |
Family
ID=93255459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560923A Pending JP2025516407A (ja) | 2023-04-27 | 2023-05-25 | Ｖｖｎ００１含有眼科組成物 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4702974A1 (https=) |
| JP (1) | JP2025516407A (https=) |
| KR (1) | KR20240159657A (https=) |
| CN (1) | CN118892446A (https=) |
| AU (1) | AU2023361985B2 (https=) |
| CA (1) | CA3238321A1 (https=) |
| IL (1) | IL312531A (https=) |
| TW (1) | TW202442220A (https=) |
| WO (1) | WO2024221527A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0589020A4 (en) * | 1992-03-18 | 1994-07-06 | Coopervision Pharma | Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration |
| US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| HUE059052T2 (hu) * | 2014-11-07 | 2022-10-28 | Santen Pharmaceutical Co Ltd | Vizes szemészeti készítmény |
| WO2019001171A1 (zh) * | 2017-06-27 | 2019-01-03 | 维眸生物科技上海有限公司 | 一种含磷化合物及其制备和应用 |
| CN109134533B (zh) * | 2017-06-27 | 2020-08-11 | 维眸生物科技（上海）有限公司 | 一种含磷化合物及其制备和应用 |
| CN114533652B (zh) * | 2018-09-25 | 2024-12-13 | 沈阳兴齐眼药股份有限公司 | 药物组合物、其制备方法和用途 |
| US20230172946A1 (en) * | 2019-08-18 | 2023-06-08 | Iview Therapeutics, Inc. | In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate |
| IT202000027155A1 (it) * | 2020-11-12 | 2022-05-12 | Sifi Spa | Formulazione a base di poliesametilene biguanide per il trattamento della cheratite da acanthamoeba |
| PL4312986T3 (pl) * | 2021-04-01 | 2025-02-17 | Active Biotech Ab | Preparat lakwinimodu do stosowania do oczu |
-
2023
- 2023-04-27 CN CN202310476403.2A patent/CN118892446A/zh active Pending
- 2023-05-25 CA CA3238321A patent/CA3238321A1/en active Pending
- 2023-05-25 AU AU2023361985A patent/AU2023361985B2/en active Active
- 2023-05-25 KR KR1020247022421A patent/KR20240159657A/ko active Pending
- 2023-05-25 JP JP2023560923A patent/JP2025516407A/ja active Pending
- 2023-05-25 WO PCT/CN2023/096273 patent/WO2024221527A1/zh not_active Ceased
- 2023-05-25 EP EP23887181.8A patent/EP4702974A1/en active Pending
- 2023-10-24 TW TW112140586A patent/TW202442220A/zh unknown
-
2024
- 2024-05-01 IL IL312531A patent/IL312531A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI849355B (zh) | 含阿托平之水性組成物及其用途 | |
| US9694003B2 (en) | Formulations and methods for treating high intraocular pressure | |
| EP3593788B1 (en) | Ophthalmic compositions containing a nitric oxide releasing prostamide | |
| JP2018177820A (ja) | 水性眼科組成物 | |
| WO1999063968A1 (fr) | Preparations aqueuses contenant des medicaments faiblement solubles | |
| JPWO2006049250A1 (ja) | 眼内移行性促進水性点眼剤 | |
| JP2025516407A5 (https=) | ||
| EP4702974A1 (en) | Ophthalmic composition containing vvn001 | |
| WO1990013284A1 (en) | Pharmaceutical composition containing sodium cromoglycate | |
| KR20230145458A (ko) | 우르소데옥시콜산 또는 그 염을 함유하는 수성 의약 조성물 | |
| EP4368179A1 (en) | Composition containing loxoprofen sodium | |
| US20230218611A1 (en) | Ophthalmic compositions comprising a combination of brinzolamide and brimonidine | |
| WO2021210646A1 (ja) | エピナスチン又はその塩を含有する水性組成物 | |
| HK40113077A (zh) | 一种含vvn001的眼科组合物 | |
| US20260060973A1 (en) | Ophthalmic Composition for Treating Non-Infectious Inflammatory Diseases | |
| WO2024034592A1 (ja) | Ｕｄｃａまたはその塩を含有する水性医薬組成物 | |
| TW202442233A (zh) | 一種用於治療非感染性炎症疾病的眼科組合物 | |
| RU2443416C2 (ru) | Капли глазные | |
| KR20250064683A (ko) | 안구 충혈 완화를 위한 아프라클로니딘을 포함하는 약제학적 조성물 | |
| HK40113256A (zh) | 一种用於治疗非感染性炎症疾病的眼科组合物 | |
| CZ13722U1 (cs) | Oční instilace se zlepšenou stabilitou účinné látky na bázi brimonidinu | |
| CN104873519A (zh) | 一种曲伏前列素眼用组合物及其制备方法 | |
| KR20120137640A (ko) | 일회용 안과 조성물 |